Similar articles

Abstract: Objective: To explore the effects of down-regulated tryptase expression in mast cells on the synthesis and release of )%29&ck%5B%5D=abstract&ck%5B%5D=keyword'>interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) of vascular endothelial cells. Methods: tryptase-siRNA (small-interfering RNA) vector was constructed to inhibit tryptase expression in P815 cells. The medium of P815 cells treated by the tryptase-siRNA (RNAi-P815 group) or pure vector (P815 group) was collected and used to culture bEnd.3 cells. The messenger RNAs (mRNAs) of IL-6 and TNF-α in bEnd.3 cells and their protein levels in the medium were measured by reverse transcription polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA), respectively. Results: IL-6 and TNF-α mRNAs in bEnd.3 cells cultured in RNAi-P815-conditioned medium decreased significantly compared to those in P815-conditioned medium. Consistently, IL-6 and TNF-α protein levels in the medium of bEnd.3 of RNAi-P815 group were lower than those of P815 group. Conclusion: Reduced tryptase expression significantly inhibited the synthesis and release of IL-6 and TNF-α in vascular endothelial cells. RNA interference targeting tryptase expression may be a new anti-inflammatory strategy for vascular diseases.

[1] Barnes, P.J., Karin, M., 1997. Nuclear factor-κB—a pivotal transcription factor in chronic inflammatory diseases. The New England Journal of Medicine, 336(15):1066-1071.

[2] Chung, C.P., Avalos, I., Raggi, P., Stein, C.M., 2007. Atherosclerosis and inflammation: insights from rheumatoid arthritis. Clinical Rheumatology, 26(8):1228-1233.

[3] Compton, S.J., Cairns, J.A., Holgate, S.T., Walls, A.F., 1998. The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release, and adhesion molecule expression: tryptase induces expression of mRNA for IL-1β and IL-8 and stimulates the selective release of IL-8 from human umbilical vein endothelial cells. The Journal of Immunology, 161:1939-1946.

[4] Eickelberg, O., Roth, M., Block, L.H., 1997. Effects of amlodipine on gene expression and extracellular matrix formation in human vascular smooth muscle cells and fibroblasts: implication for vascular protection. International Journal of Cardiology, 62:S31-S37.

[5] Gibbons, G.H., 1997. Endothelial function as a determinant of vascular function and structure: a new therapeutic target. American Journal of Cardiology, 79(12):3-8.

[6] Hou, Y.Q., Hafezi-Moghadam, A., Ley, K., 2000. Role of vascular cell adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesions. Circulation Research, 87:153-159.

[7] Kelley, J.L., Chi, D.S., Abou-Auda, W., Smith, J.K., Krishnaswamy, G., 2000. The molecular role of mast cells in atherosclerotic cardiovascular disease. Molecular Medicine Today, 6(8):304-308.

[8] Kinoshita, M., Okada, M., Hara, M., Furukawa, Y., Matsumori, A., 2005. Mast cell tryptase in mast cell granules enhances MCP-1 and IL-8 production in human endothelial cells. Arteriosclerosis Thrombosis and Vascular Biology, 25(9):1858-1863.

[9] Lee, M., Sommerhoff, C.P., von Eckardstein, A., Zettl, F., Fritz, H., Kovanen, P.T., 2002. Mast cell tryptase degrades HDL and blocks its function as an acceptor of cellular cholesterol. Artesriosclerosis Thrombosis and Vascular Biology, 22(12):2086-2091.

[10] Libby, P., 2002. Inflammation in atherosclerosis. Nature, 420:868-874.

[11] Lu, C., Wang, X.W., Zhao, F.D., Yin, L.H., 2003. Establishment of a new experimental detective assay of human serum tryptase. Fudan University Journal of Medical Sciences, 30(1):66-67 (in Chinese).

[12] Lu, C., Ma, Y.J., Mangsur, M., Zhao, F.D., Yin, L.H., 2006. Effects of mast cell tryptase on the expression of stem cell factor in endothelial cell line and its mechanism. Fudan University Journal of Medical Sciences, 33(3):291-294 (in Chinese).

[13] Macfarlane, S.R., Seatter, M.J., Kanke, T., Hunter, G.D., Plevin, R., 2001. Proteinase-activated receptors. Pharmacological Reviews, 53:245-282.

[14] Malamud, V., Vaaknin, A., Abramsky, O., Mor, M., Burgess, L.E., Ben-Yehudah, A., Lorberboum-Golski, H., 2003. Tryptase activates peripheral blood mononuclear cells causing the synthesis and release of TNF-α, IL-6 and IL-1β: possible relevance to multiple sclerosis. Journal of Neuroimmunology, 138(1-2):115-122.

[15] Mangsur, M., Ma, Y.J., Lu, C., Zhao, F.D., Yin, L.H., 2006. Effect of tryptase on the expression of IL-6 and TNF-α in microvascular endothelial cell. Fudan University Journal of Medical Sciences, 33(2):217-221 (in Chinese).

[16] Monaco, C., Andreakos, E., Kiriakidis, S., Mauri, C., Bicknell, C., Foxwell, B., Cheshire, N., Paleolog, E., Feldmann, M., 2004. Canonical pathway of nuclear factor κB activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America, 101(15):5634-5639.

[17] Ridker, P.M., Rifai, N., Stampfer, M.J., Hennekens, C.H., 2000a. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation, 101:1767-1772.

[18] Ridker, P.M., Rifai, N., Pfeffer, M., Sacks, F., Lepage, S., Braunwald, E., 2000b. Elevation of tumor necrosis factor-α and increased risk of recurrent coronary events after myocardial infarction. Circulation, 101:2149-2153.

[19] Sendo, T., Sumimura, T., Itoh, Y., Goromaru, T., Aki, K., Yano, T., Oike, M., Ito, Y., Mori, S., Nishibori, M., Oishi, R., 2003. Involvement of proteinase-activated receptor-2 in mast cell tryptase-induced barrier dysfunction in bovine aortic endothelial cells. Cellular Signalling, 15:773-781.

[20] Smalley, D.M., Lin, J.H.C., Curtis, M.L., Kobari, Y., Stemerman, M.B., Pritchard, K.A., 1996. Native LDL increases endothelial cell adhesiveness by inducing intercellular adhesion molecule-1. Arteriosclerosis, Thrombosis, and Vascular Biology, 16:585-590.

[21] Takase, B., Uehata, A., Akima, T., Nagai, T., Nishioka, T., Hamabe, A., Satomura, K., Ohsuzu, F., Kurita, A., 1998. Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease. American Journal of Cardiology, 82(12):1535-1539.

[22] van Haelst, P.L., Timmer, J.R., Grijns, H.J., Kauffman, H.F., Gans, R.O., van Doormaal, J.J., 2001. No long-lasting or intermittent mast cell activation in acute coronary syndromes. International Journal of Cardiology, 78(1):75-80.

[23] Warner, S.J., Libby, P., 1989. Human vascular smooth muscles: target for and source of tumor necrosis factor. The Journal of Immunology, 142:100-109.